Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plaque Assays
1.2.3 PCR
1.2.4 ELISA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Viral Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood & Blood Products
1.3.3 Cellular & Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue & Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Detection Market Perspective (2019-2030)
2.2 Viral Detection Growth Trends by Region
2.2.1 Global Viral Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Detection Historic Market Size by Region (2019-2024)
2.2.3 Viral Detection Forecasted Market Size by Region (2025-2030)
2.3 Viral Detection Market Dynamics
2.3.1 Viral Detection Industry Trends
2.3.2 Viral Detection Market Drivers
2.3.3 Viral Detection Market Challenges
2.3.4 Viral Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Detection Players by Revenue
3.1.1 Global Top Viral Detection Players by Revenue (2019-2024)
3.1.2 Global Viral Detection Revenue Market Share by Players (2019-2024)
3.2 Global Viral Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Detection Revenue
3.4 Global Viral Detection Market Concentration Ratio
3.4.1 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Detection Revenue in 2023
3.5 Viral Detection Key Players Head office and Area Served
3.6 Key Players Viral Detection Product Solution and Service
3.7 Date of Enter into Viral Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Detection Breakdown Data by Type
4.1 Global Viral Detection Historic Market Size by Type (2019-2024)
4.2 Global Viral Detection Forecasted Market Size by Type (2025-2030)
5 Viral Detection Breakdown Data by Application
5.1 Global Viral Detection Historic Market Size by Application (2019-2024)
5.2 Global Viral Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Detection Market Size (2019-2030)
6.2 North America Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Detection Market Size by Country (2019-2024)
6.4 North America Viral Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Detection Market Size (2019-2030)
7.2 Europe Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Detection Market Size by Country (2019-2024)
7.4 Europe Viral Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Detection Market Size (2019-2030)
8.2 Asia-Pacific Viral Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Detection Market Size (2019-2030)
9.2 Latin America Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Detection Market Size by Country (2019-2024)
9.4 Latin America Viral Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Detection Market Size (2019-2030)
10.2 Middle East & Africa Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Avance Biosciences Inc (US)
11.1.1 Avance Biosciences Inc (US) Company Detail
11.1.2 Avance Biosciences Inc (US) Business Overview
11.1.3 Avance Biosciences Inc (US) Viral Detection Introduction
11.1.4 Avance Biosciences Inc (US) Revenue in Viral Detection Business (2019-2024)
11.1.5 Avance Biosciences Inc (US) Recent Development
11.2 BSL BIOSERVICE (Germany)
11.2.1 BSL BIOSERVICE (Germany) Company Detail
11.2.2 BSL BIOSERVICE (Germany) Business Overview
11.2.3 BSL BIOSERVICE (Germany) Viral Detection Introduction
11.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2019-2024)
11.2.5 BSL BIOSERVICE (Germany) Recent Development
11.3 Clean Cells (France)
11.3.1 Clean Cells (France) Company Detail
11.3.2 Clean Cells (France) Business Overview
11.3.3 Clean Cells (France) Viral Detection Introduction
11.3.4 Clean Cells (France) Revenue in Viral Detection Business (2019-2024)
11.3.5 Clean Cells (France) Recent Development
11.4 Charles River Laboratories International, Inc (US)
11.4.1 Charles River Laboratories International, Inc (US) Company Detail
11.4.2 Charles River Laboratories International, Inc (US) Business Overview
11.4.3 Charles River Laboratories International, Inc (US) Viral Detection Introduction
11.4.4 Charles River Laboratories International, Inc (US) Revenue in Viral Detection Business (2019-2024)
11.4.5 Charles River Laboratories International, Inc (US) Recent Development
11.5 Lonza Group (Switzerland)
11.5.1 Lonza Group (Switzerland) Company Detail
11.5.2 Lonza Group (Switzerland) Business Overview
11.5.3 Lonza Group (Switzerland) Viral Detection Introduction
11.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2019-2024)
11.5.5 Lonza Group (Switzerland) Recent Development
11.6 Merck KGaA (Germany)
11.6.1 Merck KGaA (Germany) Company Detail
11.6.2 Merck KGaA (Germany) Business Overview
11.6.3 Merck KGaA (Germany) Viral Detection Introduction
11.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2019-2024)
11.6.5 Merck KGaA (Germany) Recent Development
11.7 Sigma-Aldrich Corporation (US)
11.7.1 Sigma-Aldrich Corporation (US) Company Detail
11.7.2 Sigma-Aldrich Corporation (US) Business Overview
11.7.3 Sigma-Aldrich Corporation (US) Viral Detection Introduction
11.7.4 Sigma-Aldrich Corporation (US) Revenue in Viral Detection Business (2019-2024)
11.7.5 Sigma-Aldrich Corporation (US) Recent Development
11.8 SGS S.A. (Switzerland)
11.8.1 SGS S.A. (Switzerland) Company Detail
11.8.2 SGS S.A. (Switzerland) Business Overview
11.8.3 SGS S.A. (Switzerland) Viral Detection Introduction
11.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2019-2024)
11.8.5 SGS S.A. (Switzerland) Recent Development
11.9 Texcell, Inc. (France)
11.9.1 Texcell, Inc. (France) Company Detail
11.9.2 Texcell, Inc. (France) Business Overview
11.9.3 Texcell, Inc. (France) Viral Detection Introduction
11.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2019-2024)
11.9.5 Texcell, Inc. (France) Recent Development
11.10 WuXi PharmaTech (Cayman) Inc. (China)
11.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Detail
11.10.2 WuXi PharmaTech (Cayman) Inc. (China) Business Overview
11.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Introduction
11.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2019-2024)
11.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details